Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_assertion type Assertion NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_head.
- NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_assertion description "[Captopril, an ACE inhibitor, and losartan, an AT1R blocker, decreased expression of ACE and AT1R, but increased expression of ACE2 and angiotensin II type 2 receptor in LLC cells under hypoxia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_provenance.
- NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_assertion evidence source_evidence_literature NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_provenance.
- NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_assertion SIO_000772 25511041 NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_provenance.
- NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_assertion wasDerivedFrom befree-2016 NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_provenance.
- NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_assertion wasGeneratedBy ECO_0000203 NP1248301.RABvTtXM9jy4Nx4dEMajh6rlocTm3oodhK2BowK_jQecs130_provenance.